Written by Collin Rose.
In parallel patent litigation, the one-year time bar for inter partes review has long been viewed as the principal constraint on access to the PTAB. The Director’s recent decision in Magnolia Medical v. Kurin suggests that this view is incomplete. While statutory timeliness remains necessary, it no longer defines the full scope of when PTAB review is realistically available.
The USPTO Director’s precedential denial of institution in Magnolia Medical v. Kurin underscores an increasingly important point for litigants: compliance with the one-year statutory deadline for filing an inter partes review is no longer sufficient, standing alone, to ensure access to the PTAB.
The decision does not alter the law governing the statutory time bar. Rather, it illustrates how the timing of a petition—viewed in the broader context of the litigation—can independently determine whether the PTAB will entertain review at all.
The Statutory Framework Still Matters—But It Is Not Dispositive
At first glance, the petition in Magnolia appears untimely, given that the underlying litigation had been pending for an extended period before the petition was filed. That initial impression is misleading.
The petition did not target the patents asserted at the outset of the case. Instead, it was directed to a later-issued continuation patent that was first introduced into the litigation well after the complaint was filed. Measured against that patent, the petition fell within the one-year period under § 315(b) and was therefore statutorily timely.
In that respect, the case reflects a straightforward application of the statutory rule: the one-year clock runs on a patent-by-patent basis, and newly asserted continuations can trigger a new filing window. The denial of institution did not turn on any failure to satisfy that requirement.
The Decision Turns on Sequencing, Not Formal Timeliness
The outcome instead reflects the broader litigation posture at the time the petition was filed. By that stage, the parties had already developed the validity issues in the district court through claim construction and expert proceedings, and the record showed substantial investment in those questions.
Against that backdrop, the petition appeared less like an early strategic choice and more like an effort to revisit validity after the case had taken shape—and, notably, after an adverse development in the district court. The Director’s analysis reflects a concern that PTAB review, in those circumstances, risks becoming a second pass at validity rather than a substitute for litigating it in court.
Even where a petition satisfies the statutory requirements, the perception that it follows—and responds to—developments in the district court can be sufficient to support discretionary denial.
Continuations Create Opportunity—But Also Risk
The posture in Magnolia is not unusual. Patent owners frequently assert continuation patents during the course of litigation, creating new opportunities for PTAB review based on a reset statutory clock.
This decision makes clear, however, that the existence of that window does not ensure meaningful access to the PTAB.
Where a continuation is introduced into a case that is already well underway, the PTAB may look beyond formal timing and examine the petitioner’s approach to validity across the case as a whole. If the petition appears to extend an existing invalidity strategy—rather than offer a distinct alternative to it—the fact that it targets a different patent may carry limited weight.
In practical terms, continuation practice may force earlier consideration of PTAB strategy than the statutory framework alone would suggest.
A Shift in Emphasis Toward Litigation Conduct
The decision reflects a broader shift in emphasis toward litigation conduct and sequencing. The focus is no longer limited to whether parallel proceedings exist or how close the case is to trial. Increasingly, the analysis turns on how the petition fits within the overall development of the case.
This includes when the petition is filed, how validity has already been developed in the district court, and whether the petition can reasonably be understood as an independent path to resolution. As litigation progresses, and validity issues become more fully formed, the distinction between presenting a new forum and repeating an existing dispute becomes more difficult to maintain.
While the decision does not establish a bright-line rule, it suggests that the closer a petition is filed to key developments bearing on validity, the more difficult it becomes to frame that petition as a true alternative to continued litigation.
Practical Implications for Defendants
For accused infringers, timing must now be evaluated along two dimensions. The statutory deadline remains a necessary condition, but it is no longer sufficient.
Equally important is how the petition fits within the broader litigation strategy. A petition that is technically timely may still face risk if it follows substantial development of the validity record or appears connected to specific litigation outcomes. At the same time, pursuing PTAB review earlier—before key issues are fully developed—can carry its own strategic consequences, including the scope of any resulting estoppel.
This creates a practical tension. Parties may reasonably seek clarity on claim scope or infringement theories before committing to PTAB review, but Magnolia suggests that waiting for that clarity may come at a cost. As a case matures, the ability to characterize an IPR as a substitute for district court adjudication diminishes, and the risk that it will be seen as a response to prior developments increases.
Implications for Patent Owners
For patent owners, the decision reinforces the importance of framing the petition within the sequence of events in the district court. Where a petition follows key inflection points or appears responsive to developments in expert or dispositive practice, those circumstances can support an argument that the PTAB is being used as a secondary forum rather than an alternative one.
The more a petition can be tied to issues already developed in the litigation, the more persuasive that framing is likely to be.
Framing the Takeaway
Magnolia is best understood as a refinement in how timing is evaluated, rather than a change to the governing rules.
Section 315(b) defines the outer boundary for filing a petition. The decision makes clear that this boundary does not define the full scope of practical access to PTAB review. That scope may narrow over the life of a case, depending on how validity issues have developed and when the petition is filed.
For parties navigating cases involving continuation practice, the key question is no longer simply whether an IPR can be filed within one year of service. It is whether, at the time of filing, the petition can still be viewed as a genuinely independent avenue for resolving validity—or whether it will instead be seen as an effort to revisit issues that have already taken shape elsewhere.
